Target
Galectin-9
Ligand
BDBM50509532
Substrate
n/a
Meas. Tech.
ChEMBL_1838663 (CHEMBL4338796)
Kd
4600±n/a nM
Citation
 Mahanti, MPal, KBSundin, APLeffler, HNilsson, UJ Epimers Switch Galectin-9 Domain Selectivity: 3 ACS Med Chem Lett 11:34-39 (2020) [PubMed]  Article 
Target
Name:
Galectin-9
Synonyms:
LEG9_HUMAN | LGALS9
Type:
PROTEIN
Mol. Mass.:
39532.33
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1454626
Residue:
355
Sequence:
MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQNPRTVPVQPAFSTVPFSQPVCFPPRPRGRRQKPPGVWPANPAPITQTVIHTVQSAPGQMFSTPAIPPMMYPHPAYPMPFITTILGGLYPSKSILLSGTVLPSAQRFHINLCSGNHIAFHLNPRFDENAVVRNTQIDNSWGSEERSLPRKMPFVRGQSFSVWILCEAHCLKVAVDGQHLFEYYHRLRNLPTINRLEVGGDIQLTHVQT
  
Inhibitor
Name:
BDBM50509532
Synonyms:
CHEMBL4465115
Type:
Small organic molecule
Emp. Form.:
C18H18Cl3NO4S
Mol. Mass.:
450.764
SMILES:
OC[C@H]1O[C@H](Sc2ccc(Cl)c(Cl)c2)[C@H](O)[C@@H](Nc2cccc(Cl)c2)[C@H]1O |r|
Structure:
Search PDB for entries with ligand similarity: